Back to search

Article

The potential clinical impact and cost-effectiveness of a variant-adapted 2024 Winter and Summer COVID-19 mRNA vaccination campaign in Australia

2024-12-19

Abstract excerpt

<h4>Objectives</h4> To assess the clinical and economic impact, and cost-effectiveness, of a 2024 Winter and Summer COVID-19 Vaccination Campaign (2024 Vaccination Campaign) in Australia compared to no 2024 Vaccination Campaign. <h4>Design</h4> Modelling study using a COVID-19 susceptible-exposed-infect-recovered (SEIR) dynamic transmission model and a COVID-19 vaccination and infections consequences decision anal...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5e208a7e-38af-5951-8e47-9a33623e8769
DOI
10.1101/2024.12.18.24319245
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The potential clinical impact and cost-effectiveness of a variant-adapted 2024 Winter and Summer COVID-19 mRNA vaccination campaign in AustraliaDOI 10.1101/2024.12.18.24319245
Modeling the Cost-Effectiveness of the Next-Generation COVID-19 mRNA-1283 vaccine in the United StatesSemantic proximity
The potential clinical impact and cost-effectiveness of the updated COVID-19 mRNA Fall 2023 vaccines in the United StatesSemantic proximity
Effectiveness of the 2023-2024 Omicron XBB.1.5-containing mRNA COVID-19 vaccine (mRNA-1273.815) in preventing COVID-19-related hospitalizations and medical encounters among adults in the United States: An interim analysisSemantic proximity
Substantial reduction in the clinical and economic burden of disease following variant-adapted mRNA COVID-19 vaccines in immunocompromised patients in FranceSemantic proximity
Effectiveness of Mrna Booster Vaccination Against Mild and Severe COVID-19 During Delta and Omicron Variant Circulation in Germany: An Analysis of National Surveillance DataSemantic proximity
Real-World Effectiveness of the mRNA-1273 Vaccine Against COVID-19: Interim Results from a Prospective Observational Cohort StudySemantic proximity
Effectiveness of the 2023–2024 Omicron XBB.1.5-containing mRNA COVID-19 Vaccine (mRNA-1273.815) in Preventing COVID-19–related Hospitalizations and Medical Encounters Among Adults in the United StatesSemantic proximity
The Potential Clinical and Economic Impact of the Next-Generation COVID-19 mRNA-1283 Vaccine in CanadaSemantic proximity
Changing impact of COVID-19 vaccination on COVID-19 mortality in the SARS-CoV-2 omicron variant period, 2022-2025Semantic proximity
Modeling the Anticipated Public Health Benefits of the Next-Generation COVID-19 mRNA-1283 vaccine: An Interim U.S. Population-Level Impact AssessmentSemantic proximity
Clinical and Economic impact of updated Fall 2023 COVID-19 vaccines in the Immunocompromised Population in CanadaSemantic proximity
Effectiveness of the Third mRNA Vaccine Dose Against COVID-19 During the Omicron Variant Dominant Period: A Systematic Review and Meta-AnalysisSemantic proximity
Select a neighboring publication to make it the new centre.